ストックスクリーナーアプリを入手
8.35
0.94%
-0.12
Kura Oncology Inc (KURA) 最新ニュース
Kura oncology CSO Burrows sells $11k in shares By Investing.com - Investing.com India
Kura Oncology’s chief medical officer, Leoni, sells $69k in stock By Investing.com - Investing.com South Africa
Kura Oncology CCO Powl sells $54,266 in stock By Investing.com - Investing.com Australia
Kura Oncology SVP sells $60k in shares By Investing.com - Investing.com India
Kura Oncology COO Ford sells $15,339 in stock - Investing.com
Kura Oncology SVP sells $60k in shares - Investing.com
Kura Oncology’s chief legal officer sells $94,827 in stock - Investing.com
Kura Oncology CCO Powl sells $54,266 in stock - Investing.com
Kura oncology CSO Burrows sells $11k in shares - Investing.com
Understanding Momentum Shifts in (KURA) - Stock Traders Daily
Sector Gamma AS Takes $3.88 Million Position in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology, Inc. (KURA) Rating Update: 258% Potential Upside Highlights Growth Potential In Biotech Sector - DirectorsTalk Interviews
Kura Oncology (NASDAQ:KURA) Cut to "Strong Sell" at Zacks Research - MarketBeat
Kura Oncology: Safety Profile Of Komzifti Supports My Upgrade To Strong Buy (NASDAQ:KURA) - Seeking Alpha
Kura Oncology (NASDAQ:KURA) Nasdaq 100 Index Clinical Research Focus - Kalkine Media
Jim Cramer calls Kura speculative but says "It's one of the stronger ones I've seen in a very long time" - MSN
Does Kura Oncology (NASDAQ:KURA) Have A Healthy Balance Sheet? - 富途资讯
Kura Oncology, Inc. (NASDAQ:KURA) Short Interest Up 37.5% in December - MarketBeat
Kura Oncology's finance SVP sells shares worth $38,958 - MSN
Kura Oncology price target lowered to $20 from $25 at Leerink - Yahoo Finance
FY2025 EPS Forecast for Kura Oncology Reduced by Analyst - MarketBeat
Kura Oncology (KURA) Receives a Buy from Leerink Partners - The Globe and Mail
Inflation Data: Will Kura Oncology Inc stock keep outperforming rivalsJuly 2025 PreEarnings & Risk Controlled Swing Alerts - Bộ Nội Vụ
KURA: HC Wainwright & Co. Reiterates 'Buy' Rating and $40 PT | K - GuruFocus
Kura Oncology (NASDAQ:KURA) Given "Buy" Rating at HC Wainwright - MarketBeat
Stock Recap: Whats the profit margin of Kura Oncology IncIPO Watch & AI Based Trade Execution Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Cerus (CERS) and Kura Oncology (KURA) - The Globe and Mail
Kura Oncology 8-K Filing Analysis - TradingView
Kura Oncology Posts $2.1M Initial KOMZIFTI Sales, Secures $195M Milestone - Nasdaq
Kura Oncology Announces Launch of KOMZIFTI™ (ziftomenib) and Preliminary $2.1 Million Revenue Following FDA Approval for R/R NPM1-mutated AML - Quiver Quantitative
Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones - The Manila Times
Kura Oncology wins FDA approval for leukemia drug - MSN
Is Kura Oncology Inc. stock affected by interest rate hikesTrade Performance Summary & Fast Gain Stock Tips - Улправда
How Komzifti Is Rewriting The Kura Oncology (KURA) Story For Analysts And Investors - Yahoo Finance
Can Kura Oncology Inc. stock sustain institutional interestJuly 2025 Selloffs & Daily Entry Point Trade Alerts - Улправда
Rate Cut: Will Kura Oncology Inc. stock see insider buyingEarnings Summary Report & Consistent Return Strategy Ideas - Улправда
Aug Intraday: Is Kura Oncology Inc. stock affected by interest rate hikesWeekly Stock Analysis & Verified Swing Trading Watchlist - Улправда
FY2025 EPS Forecast for Kura Oncology Decreased by Analyst - MarketBeat
Research Analysts Set Expectations for Kura Oncology FY2030 Earnings - MarketBeat
Kura Oncology (NASDAQ:KURA) Stock Price Down 6.1%Here's Why - MarketBeat
Kura Oncology reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Kura Oncology (KURA) Grants Stock Options to New Employees - GuruFocus
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Discipline and Rules-Based Execution in KURA Response - Stock Traders Daily
What analysts say about Kura Oncology Inc stockGeopolitical Risk Analysis & Affordable Trading Portfolio - earlytimes.in
Is Kura Oncology Inc a good long term investmentPrice-to-Book Ratio Updates & Maximize Gains Professionally - earlytimes.in
Kura Oncology Stock: Biotech Battleground With High Hopes And Higher Volatility - AD HOC NEWS
Kura Oncology shows market leadership with jump to 93 RS rating - MSN
Kura Oncology rises following Jim Cramer comments - MSN
(KURA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Jim Cramer Calls Kura Speculative But Says "It's One of the Stronger Ones I've Seen in a Very Long Time" - Finviz
0.60%
4.32%
大文字化:
|
ボリューム (24 時間):